Oman Cardiovascular Clinical Trials Market Size & Outlook
Related Markets
Oman cardiovascular clinical trials market highlights
- The Oman cardiovascular clinical trials market generated a revenue of USD 6.1 million in 2025 and is expected to reach USD 10.0 million by 2033.
- The Oman market is expected to grow at a CAGR of 6.6% from 2026 to 2033.
- In terms of segment, phase iii was the largest revenue generating phase in 2025.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Cardiovascular clinical trials market data book summary
| Market revenue in 2025 | USD 6.1 million |
| Market revenue in 2033 | USD 10.0 million |
| Growth rate | 6.6% (CAGR from 2026 to 2033) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
| Key market players worldwide | IQVIA Holdings Inc, Icon PLC, SGS AG, Eli Lilly and Co, Syneos Health, Caidya, Worldwide Clinical Trials, Vial, Medpace Holdings Inc, Veeda Clinical Research, Thermo Fisher Scientific Inc |
Other key industry trends
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, South Africa cardiovascular clinical trials market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 28.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cardiovascular Clinical Trials Market Scope
Cardiovascular Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Veeda Clinical Research | View profile | 501-1000 | Ahmedabad, Gujarat, India, Asia | https://veedacr.com/ |
| Caidya | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.caidya.com |
| Worldwide Clinical Trials | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.worldwide.com |
| Vial | View profile | 101-250 | San Francisco, California, United States, North America | https://vial.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| SGS AG | View profile | 103193 | 1 Place des Alpes, P.O. Box 2152, Geneva, Switzerland, CH-1211 | https://www.sgs.com |
| IQVIA Holdings Inc | View profile | 87000 | 2400 Ellis Road, Durham, NC, United States, 27703 | https://www.iqvia.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Oman cardiovascular clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiovascular clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 63.93% in 2025. Horizon Databook has segmented the Oman cardiovascular clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Oman cardiovascular clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oman cardiovascular clinical trials market databook
-
Our clientele includes a mix of cardiovascular clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Oman cardiovascular clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into Oman cardiovascular clinical trials market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Oman cardiovascular clinical trials market size, by phase, 2021-2033 (US$M)
Oman Cardiovascular Clinical Trials Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
